Description

AOD-9604 – 5 mg

(Fragment 177-191 of Human Growth Hormone)

AOD-9604 is a synthetic peptide fragment derived from the C-terminal end (amino acids 177-191) of the human growth hormone (hGH) molecule. It was developed to isolate the lipolytic (fat-metabolizing) effects of hGH without influencing blood glucose levels or stimulating cell proliferation. Research on AOD-9604 has focused on its potential to promote fat oxidation, improve lipid metabolism, and support body-composition modulation in experimental models.

Unlike native growth hormone, AOD-9604 selectively activates fat-metabolism pathways without the broader endocrine effects associated with full-length hGH, making it an attractive subject for metabolic and obesity-related research.

---

Mechanism of Action (Based on Preclinical and Clinical Research):

• Lipolytic activity: Stimulates the breakdown of stored triglycerides into free fatty acids, enhancing fat metabolism.

• Anti-lipogenic activity: Inhibits the conversion of non-fatty food materials into body fat.

• No GH receptor activation: Does not raise IGF-1 levels or exhibit mitogenic properties linked to growth hormone.

• Metabolic regulation: Modulates fat utilization and energy expenditure without altering glucose tolerance or inducing hyperglycemia.

---

Potential Benefits (Based on Preclinical Research):

• Reduction of adipose tissue in animal and cell-culture studies

• Increased fat oxidation and improved lipid utilization

• Maintenance of lean muscle mass during weight-management protocols

• Investigated for potential joint-protective and cartilage-repair properties

• Explored for applications in obesity, metabolic, and degenerative-tissue research

---

For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory agency and is intended solely for laboratory research.